Avid Bioservices (NASDAQ: CDMO) is a USA based CDMO with nearly 3 decades of experience developing and manufacturing biopharmaceutical drug substances derived from mammalian cell culture. The scope of our services ranges from standalone analytical and process development projects to full development and CGMP manufacturing for both clinical and commercial.